- ►bmj.com [PDF] LJ Clifford, JD Rossiter - British Medical Journal, 2004 - bjo.bmj.com If you have a burning desire to respond to a paper published in BJO, why not
make use of our ''rapid response'' option? Log onto our website
(www.bjophthalmol. com), find the paper that interests you, and send your ... Cited by 4 - Related articles - All 8 versions
[CITATION] Long-term efficacy and safety of adalimumab treatment in a single-center cohort of Crohn's …
K Karmiris, M Noman, F Schnitzler, H Fidder, … - Abstract presented at: Digestive Disease Week Cited by 5 - Related articles
CW Lees, J Ironside, WAH Wallace, J … - New England Journal of Medicine, 2008 - content.nejm.org To the Editor: We report the development of locally advanced non–small-cell
lung cancer (tumor–node–metastasis [TNM] stage T4N2M0) in a 69-year-old
woman with Crohn's colitis. Her condition had been diagnosed in 2000 and ... Cited by 4 - Related articles - All 4 versions
CW Lees, A Ali, AI Thompson, GT Ho, RO … - Alimentary pharmacology & therapeutics, 2008 - ncbi.nlm.nih.gov Background and Aims. Anti-TNF agents are now widely used in Crohn's disease
(CD), and in ulcerative colitis (UC). We reviewed the safety profile of these
agents in all patients treated with infliximab in Edinburgh from 1999-2007. ... Cited by 5 - Related articles
- ►nih.gov DR Gaya, S Aitken, J Fennell, J Satsangi, AG … - British Medical Journal, 2006 - gut.bmj.com EUS could detect ascites missed by CT scan I read with great interest the
article by Lee and colleagues (Gut 2005;54:1541–5) regard- ing the accuracy of
endoscopic ultrasonogra- phy (EUS) in diagnosing ascites and predicting ... Cited by 6 - Related articles - All 5 versions
S LEVY, N ABDELLI, MD DIEBOLD, A GROSS … - Gastroentérologie clinique et biologique, 2003 - cat.inist.fr Chez les malades ayant une hépatite chronique C, l'interféron-alpha peut
induire ou exacerber des maladies auto-immunes telles qu'une thyroïdite ou un
diabète de type 1[1, 2]. D'autres organes endocrines, comme le cortex ... Cited by 1 - Related articles
R Gaulke - Zeitschrift für Rheumatologie, 2003 - Springer Mit der Einführung zytokinhemmender Moleküle (re- kombinanter löslicher
Tumornekrosefaktor (TNF)- a-Rezeptor/Etanercept, chimärer monoklonaler TNF-
a-Antikörper/Infliximab und Interleukin-1-Rezeptor- Antagonist/Anakinra), ... Cited by 1 - Related articles - All 2 versions
G He, LX Yu, WF Deng - Di 1 jun yi da xue xue bao= Academic journal of the …, 2004 - ncbi.nlm.nih.gov OBJECTIVES: To observe the clinical efficacy and safety of three-dose regimen of
Zenapax combined with tacrolimus (FK506), mycophenolate mofetil (MMF), and
steroid in the early-stage management of liver transplantation. METHOD: ... Cited by 1 - Related articles
B WISNIEWSKI, J DENIS, D FISCHER, D … - Gastroentérologie clinique et biologique, 2004 - cat.inist.fr Le traitement de l'hépatite chronique C repose sur une bithérapie associant
l'interféron alpha à la ribavirine. Les effets secondaires de l'interféron
alpha sont nombreux et peuvent dans certains cas conduire à interrompre ... Cited by 1 - Related articles
[CITATION] Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C
